Skip to main content
. 2023 Jan 12;15(1):274. doi: 10.3390/pharmaceutics15010274

Figure 8.

Figure 8

Antimicrobial studies against S. aureus using T705, MIL-101(Fe) and T705-loaded MIL-101(Fe). (A) Plot showing the viability studies on S. aureus of favipiravir, MIL-101(Fe) and T705-loaded MIL-101(Fe). (B) MIC (marked with red) using different concentrations of T705-loaded MIL-101(Fe). (C) Disk diffusion studies, showing MBC at 0.0032 g mL−1. (D) Growth curves under different concentrations of loaded MOFs. Reproduced with permission from [69].